Previous Article | Next Article 
Journal of Virology, July 2000, p. 6476-6484, Vol. 74, No. 14
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Infection of Polarized Cultures of Human Intestinal
Epithelial Cells with Hepatitis A Virus: Vectorial Release of Progeny
Virions through Apical Cellular Membranes
Christian A.
Blank,1
David A.
Anderson,2
Michael
Beard,3 and
Stanley M.
Lemon3,*
Department of Internal Medicine I, University
of Regensburg, 93042 Regensburg, Germany1;
Hepatitis Research Unit, Macfarlane-Burnett Center for Medical
Research, Fairfield, Victoria 3078, Australia2;
and Department of Microbiology and Immunology, The University
of Texas Medical Branch at Galveston, Galveston, Texas
77555-10193
Received 16 December 1999/Accepted 24 April 2000
 |
ABSTRACT |
Although hepatitis A virus (HAV) is typically transmitted by the
fecal-oral route, little is known of its interactions with cells of the
gastrointestinal tract. We studied the replication of HAV in polarized
cultures of Caco-2 cells, a human cell line which retains many
differentiated functions of small intestinal epithelial cells. Virus
uptake was 30- to 40-fold more efficient when the inoculum was placed
on the apical rather than the basolateral surface of these cells,
suggesting a greater abundance of the cellular receptor for HAV on the
apical surface. Infection proceeded without cytopathic effect and did
not influence transepithelial resistance or the diffusion of inulin
across cell monolayers. Nonetheless, there was extensive release of
progeny virus, which occurred almost exclusively into apical
supernatant fluids (36.4% ± 12.5% of the total virus yield compared
with 0.23% ± 0.13% release into basolateral fluids). Brefeldin A
caused a profound inhibition of HAV replication, but also selectively
reduced apical release of virus. These results indicate that polarized
human epithelial cell cultures undergo vectorial infection with HAV and
that virus release is largely restricted to the apical membrane. Virus
release occurs in the absence of cytopathic effect and may involve
cellular vesicular transport mechanisms.
 |
INTRODUCTION |
Human hepatitis A virus (HAV) is a
nonenveloped virus with a single-stranded, 7.5-kb positive-sense RNA
genome (17, 18). It is classified as the type species of the
genus Hepatovirus within the family
Picornaviridae and is a common cause of both sporadic and
epidemic acute hepatitis in humans (17, 19). The
transmission of HAV is generally due to the ingestion of material contaminated with feces containing HAV. However, the pathological sequence of events that begins with entry of the virus via the gastrointestinal tract and ultimately results in hepatitis is not well
understood. A primary, extrahepatic site of replication for this highly
hepatotropic agent has long been postulated, but has proven difficult
to demonstrate. Early experiments involving immunohistologic evaluation
of intestinal tissue from infected nonhuman primates provided no
evidence for the presence of virus within the gastrointestinal mucosa.
Both Mathiesen et al. (25) and Krawczynski et al.
(16) were unable to identify viral antigen in the gut of
enterically infected primates. However, more recent studies, possibly
with better immunologic reagents, have resulted in the demonstration of
HAV antigen within cells of the small intestine. Karayiannis et al.
(14) found specific HAV antigen within the cytoplasm of
~3% of cells in duodenal biopsies from two of three tamarins
(Saguinus labiatus) infected intravenously with a
tamarin-adapted HAV variant. Similarly, Asher et al. (2) demonstrated the presence of HAV antigen in the cytoplasm of epithelial cells lining small intestinal crypts within 3 days of the oral inoculation of New World owl monkeys (Aotus trivirgatus)
with virus. In these animals, virus was present in the gut prior to its
detection within hepatocytes (2). Thus, studies in two different animal species suggest that small intestinal epithelial cells
serve as a primary site of replication for HAV.
The cells which form the small intestinal epithelium are highly
polarized, with differential expression of specific proteins on their
apical (lumenal) and basolateral (basement membrane) surfaces which
contributes to the numerous specialized secretory and absorptive
functions of these cells. Relatively little is known of the
interactions of nonenveloped viruses with such polarized cells,
although it seems likely that these interactions play important roles
in determining the pathogenesis of a wide variety of intestinal viral
infections. In the case of HAV, such interactions are of special
interest because the major cell type which supports replication, the
hepatocyte, is also highly polarized and of epithelial origin (6,
11). The apical surface of the hepatocyte forms a well demarcated
groove which encircles the cell and provides access to the biliary
canaliculi through which components of bile (including HAV during acute
hepatitis A) are secreted from the liver into the feces (6, 10,
31). The extended basilar surface of the hepatocyte is exposed to
the space of Dissë and through it to the venous sinusoids, via
which HAV is likely to reach the liver during the early stages of the
infection. HAV appears to infect hepatocytes without cytopathic effect,
and much higher virus titers are found in bile and in stool than in
blood (17). Thus, a mechanism exists by which progeny viral
particles are secreted in a vectorial fashion from the hepatocyte into
the bile. It is tempting to speculate that this process may involve
either the normal vesicular cellular protein sorting system or perhaps specialized hepatocellular transporter proteins involved in secretion of biliary lipids (phosphotidylcholine) and bile salts at the canalicular membrane (6, 30). However, there are no data available which address this issue.
To establish a system in which we could begin to investigate
interactions of HAV with polarized epithelial cells, we sought to
determine whether the human colonic epithelial cell line, Caco-2, is
permissive for replication of HAV. Caco-2 cells most closely resemble
epithelial cells of small intestinal villi and crypts (9,
29) and are thus likely to be similar to cells of the small
intestine that are infected by HAV in vivo (2). They were
originally derived from a human colonic adenocarcinoma and show
evidence of spontaneous differentiation and polarization, especially
when grown on a porous support. They express several enzyme activities
which are peculiar to human small intestinal epithelial cells and form
apical microvilli and prominent tight junctions (9, 28).
Furthermore, when grown on a porous support, monolayers of Caco-2 cells
transport water and ions to their basolateral surface, generate a high
transepithelial electrical resistance, and develop a strong barrier to
diffusion of small molecules like inulin.
Here, we present evidence that the uptake of HAV into polarized
cultures of Caco-2 cells occurs with greater efficiency on the apical
surface of the cells, in contrast to poliovirus, a distantly related
picornavirus that is capable of bidirectional entry into these cells
(36). Unlike poliovirus, HAV replication occurs without
cytopathic effect or disruption of the transepithelial resistance
displayed by polarized monolayer cultures. Despite this, there is
extensive release of newly replicated progeny HAV in a vectorial
fashion across the apical surfaces of Caco-2 cells. The apical release
of HAV is selectively inhibited by brefeldin A, suggesting that it is
mediated by a vesicular transport mechanism.
 |
MATERIALS AND METHODS |
Cells.
Caco-2 cells (HTB-37) were obtained from the American
Type Culture Collection, Rockville, Md., and used between passages 18 and 36. The cells were maintained at 35.5°C in a 5% CO2
atmosphere in Dulbecco's modified medium with Earle's salts (DMEM),
4,500 mg of glucose/liter, and 25 mM HEPES (Gibco/BRL, Grand Island, N.Y.) supplemented with 20% fetal bovine serum (Irvine Scientific, Irvine, Calif.), 1% nonessential amino acids (Gibco), streptomycin (100 µg/ml), and penicillin (100 U/ml). Cells were grown in
75-cm2 T-flasks (Corning, Cambridge, Mass.) and passaged
every 5 to 7 days at a 1:10 split ratio. Confluency was reached within
5 to 7 days after passage.
For growth of Caco-2 cells on porous supports, we evaluated two types
of commercial cell culture inserts. In preliminary studies, we found
that BioCoat Collagen I inserts (Collaborative Research, Inc., Bedford,
Mass.) with a nominal 0.45-µm pore size were completely impermeable
to HAV (data not shown). Furthermore, Caco-2 cells cultured on BioCoat
Collagen I inserts demonstrated overgrowth and irregular
transepithelial electrical resistance measurements within 4 days of
seeding, suggesting that the cells maintained a polarized state for
only 2 or 3 days. Thus, the experiments reported herein were carried
out by using Transwell-COL tissue culture inserts (Costar Corp.,
Cambridge, Mass.) with a 0.33-cm2 growth area and 0.4-µm
pore size. The permeability of these supports to HAV was confirmed by
directly assessing the diffusion of virus across the membrane in the
absence of a cell monolayer (see Results). Hydrated Transwell-COL
inserts were seeded with 1.4 × 105 Caco-2 cells and
incubated at 35.5°C in a 5% CO2 atmosphere for at least
7 days prior to infection. The medium (0.2 ml in the insert and 0.9 ml
in the well) was replaced at 2-day intervals. Confluent monolayers
contained approximately 3.5 × 105 cells per insert at
the time of virus infection.
African green monkey kidney (BS-C-1) cells, between passage levels 93 and 98, were used for propagation and quantitation of
HAV and were
grown as monolayers in Eagle's minimal essential
medium with Earle's
salts (Gibco/BRL) supplemented with 100 mM
glutamine, streptomycin (100 µg/ml), penicillin (100 U/ml), and
2 to 10% fetal bovine
serum.
Assessment of Caco-2 cell monolayer integrity.
The integrity
of Caco-2 monolayers was assessed by measurements of transepithelial
electrical resistance and permeability of the monolayers to
[3H]inulin. The electrical resistance displayed by warm
inserts in cell culture medium was measured with a Millicell ERS
apparatus (Millipore, Bedford, Mass.) according to the manufacturer's
instructions. Only intact monolayers with a resistance of >480
(158
-cm2) were used for infection studies. The
background resistance of membranes without cells was approximately 130
(43
-cm2). For measurements of monolayer
permeability, 100 µl of DMEM containing 2.5 µCi of
[3H]inulin (DuPont NEN Research Products, Boston, Mass.)
was added to the insert, and 600 µl of medium was added to the well.
Basolateral fluid samples (20 µl) were taken at 90 min. Similar
permeability measurements were obtained with 30- and 60-min samplings
of the basolateral fluids. A rate of inulin diffusion of less than
1%/h across the insert was considered indicative of intact junctional complexes between cells (36). Diffusion across membranes in the absence of cells was approximately 61%/h.
Virus.
To facilitate preparation of a virus inoculum and
quantitation of virus yields, infections of Caco-2 cells were carried
out with the HM175/18f variant of human HAV, which is highly adapted to
growth in BS-C-1 cells (22). This virus displays a rapid replication/cytopathic (rr/cpe+) phenotype in
these cells. The virus inoculum for Caco-2 infections consisted of
chloroform-extracted, clarified supernatant fluids, collected 2 weeks
following inoculation of a BS-C-1 cell culture with virus, and
contained 2.1 × 107 radioimmunofocus-forming units
(RFU) of virus per ml (21). For polarized Caco-2 cell
infections, equal quantities of virus were allowed to adsorb to either
the apical or basolateral cell surface for 2 h at 35.5°C at a
multiplicity of infection (MOI) of approximately 6. Since the volumes
of the inoculum differed between the apical and basolateral surfaces
(0.2 and 0.9 ml, respectively), the concentration of virus present in
the basolateral inocula was 22% that of the apical inocula. Following
virus adsorption, cells were washed twice on both sides with cell
culture medium. The cell culture medium was replaced subsequently on a
daily basis. All infections were done in duplicate or triplicate.
Samples were taken for virus titration at daily intervals following
inoculation of Caco-2 cells, with the first sample (time
0) collected
immediately following adsorption of the virus. Apical
and basolateral
supernatant fluids were aspirated from the cultures,
and the cell
sheets were washed on both sides. Lysates of Caco-2
cells were made by
the addition of 0.2 ml of 0.1% sodium dodecyl
sulfate in Hanks'
balanced salt solution to inserts. The supernatant
fluids and cell
lysates were stored at

70°C until virus titers
were measured in
BS-C-1 cells by a quantal radioimmunofocus assay,
as described
previously (
21). Results are reported as RFU per
milliliter
or as RFU per culture (individual cell culture insert).
For
immunofluorescence detection of HAV antigen, infected Caco-2
monolayers
were fixed with acetone at 4°C for 15 min and stained
with a 1:250
dilution of a monoclonal anti-HAV antibody (K3-2F2).
Nuclei were
counterstained with DAPI (4',6'-diamidino-2-phenylindole).
After
extensive washing in PBS, cells were incubated with a 1:64
dilution of
fluorescein-labeled goat anti-mouse immunoglobulin
(Sigma
Immunochemicals, St. Louis, Mo.), and examined under a
Zeiss
epifluorescence
microscope.
Inhibition of vesicular transport with brefeldin A and
monensin.
A stock solution was prepared by dissolving crystalline
brefeldin A (Epicenter Technologies Corp., Madison, Wis.) in ethanol at
10 mg/ml. For treatment of apically infected Caco-2 cells (see Results), cells were fed with medium containing various concentrations of brefeldin A (0.05 to 10 µg/ml) commencing immediately after the
2-h virus adsorption period (time 0) or 18, 36, or 54 h later. Because brefeldin A is rapidly metabolized, it was replenished every
6 h with daily complete changes of medium. Toxic effects resulting
in morphological changes and a dramatic decrease in transepithelial
resistance occurred within 18 h of exposure to even minimal
concentrations of brefeldin A. Monensin (Sigma Chemical Co.) was
dissolved in ethanol at a concentration of 1 mM; further dilutions were
made in growth medium. At 72 h following infection of Caco-2 cells
from the apical side, the medium was replaced with media containing
concentrations of 10
7, 10
8, and
10
9 M monensin. After 6 h of additional incubation,
cell lysates and apical and basolateral supernatant fluids were
collected and assayed for infectious virus.
 |
RESULTS |
Caco-2 cells are permissive for replication of cell culture-adapted
HAV.
Because there is no published evidence that cultured human
colonic epithelial cells are permissive for replication of HAV, we
first assessed the ability of monolayer cultures of Caco-2 cells grown
on an impermeable polystyrene surface to support replication of the
virus under one-step growth conditions. Following inoculation of these
cells with the monkey kidney cell culture-adapted HM175/18f virus
(22) at an MOI of 4.9, the titer of cell-associated
infectious virus increased logarithmically between 24 and 72 h
postinoculation (Fig. 1). Thus, Caco-2 cells are permissive for
replication of a cell culture-adapted human HAV strain. However,
HM175/18f virus replication appeared to occur more slowly than in
BS-C-1 cells, in which the period of exponential increase in titer is
between 12 and 24 h postinoculation (Fig.
1) (22). Virus yields were also approximately 10-fold less in Caco-2 cells than in BS-C-1 cells at
150 h following inoculation. To determine the proportion of Caco-2
cells that are permissive for HAV replication, monolayer cultures were
infected at an MOI of 6.0 and assayed for HAV antigen expression by
indirect immunofluorescence 4, 8, and 12 days later (Fig.
2). By 4 days postinfection,
approximately 50% of the cells contained detectable levels of HAV
antigen (data not shown). Consistent with the one-step growth curve
shown in Fig. 1, the proportion of infected cells increased
significantly between days 4 and 8. By 8 days after inoculation, the
majority (>80%) of cells contained characteristic fine punctate
cytoplasmic fluorescence typical of HAV (Fig. 2B). The antigen-specific
staining increased in intensity and involved virtually all cells by 12 days following inoculation (Fig. 2C). We conclude from these results
that Caco-2 cells are permissive for replication of a cell
culture-adapted HAV variant, although replication proceeds relatively
slowly and to a lower overall titer in these cells than in monkey
kidney cells (Fig. 1).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
Replication of cell culture-adapted HAV under one-step
conditions in cultures of Caco-2 cells grown on an impermeable plastic
surface ( ; MOI = 4.9 RFU/cell) and in nonpolarized BS-C-1 cells
( ; MOI = 4.5 RFU/cell).
|
|

View larger version (104K):
[in this window]
[in a new window]
|
FIG. 2.
Indirect immunofluorescence detection of HAV antigen in
infected Caco-2 cells. (A) Normal uninfected Caco-2 monolayer with DAPI
nuclear counterstain. (B) Caco-2 cells 8 days following infection with
HAV at an MOI of 6.0. The inset shows a high-power view of the
cytoplasmic distribution of punctate HAV-specific fluorescence in two
cells (no counterstain). (C) Caco-2 cells 12 days following infection
with HAV. Viral antigen was visualized with a monoclonal antibody
reactive with the virus capsid.
|
|
We also assessed the ability of Caco-2 cells to support replication of
wild-type virus. For these studies, Caco-2 cells grown
on plastic were
inoculated directly with a chloroform-extracted
suspension of a primate
fecal sample containing infectious wild-type
human HAV (HM175 strain).
Subsequent analysis failed to demonstrate
intracellular levels of virus
that were detectable by radioimmunoassay
(
20) or
radioimmunofocus assay in BS-C-1 cells, even following
three to six
serial blind passages of 2 weeks each (data not shown).
Thus,
subsequent experiments were carried out with the cell culture-adapted
HM175/18f virus. The genetic differences that distinguish this
virus
from its wild-type parent suggest that modifications in
viral
components that function in cap-independent translation
and RNA
replication are of the greatest importance to its ability
to replicate
efficiently in cultured cells (
41). The amino acid
sequences
of the capsid proteins of the cell culture-adapted virus
differ
minimally from that of wild-type virus (
22). This makes
it
likely that the processes of cellular entry and release are
not
fundamentally altered by the adaptation of this virus to growth
in
monkey kidney cell
cultures.
HAV entry into polarized Caco-2 colonic epithelial cells occurs in
an asymmetric manner.
To determine whether polarized cultures of
Caco-2 cells could be infected with HAV via either the apical or
basolateral cell surfaces, the virus was allowed to adsorb to either
domain of well established, polarized Caco-2 cell monolayers grown on
porous Transwell-COL membranes. Inocula placed on either side of the membrane contained identical quantities of virus, representing an MOI
of approximately 6, but a difference in the volume of the medium
resulted in a variance in the concentration of virus in the two
chambers (see Materials and Methods). The capacity of HAV to establish
a productive infection was determined by measuring cell-associated,
infectious HAV by radioimmunofocus assay in BS-C-1 cells. Lysates of
inoculated Caco-2 cells were prepared immediately after the 2-h virus
adsorption period (time 0) and at periodic intervals up to 7 days.
These results demonstrated that HAV infection proceeded much more
efficiently following inoculation of the apical surface of polarized
Caco-2 cells (Fig. 3). The quantity of
cell-associated virus increased exponentially over 3 to 7 days
following apical inoculation, with the final virus titer approximately
330-fold greater than the quantity of virus present immediately after
adsorption. At 24 and 72 h postinfection, respectively, the titer
of cell-associated HAV was 500- to 1,000-fold higher in cells infected
via the apical surface compared to that in those infected via the
basolateral surface. The magnitude of this difference was progressively
reduced at 5 and 7 days postinfection, most likely reflecting
second-cycle infections of Caco-2 cells by virus released into the
apical supernatant fluids by a small number of cells infected following
basolateral inoculation (Fig. 3) (see below).

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 3.
Cell-associated HAV following inoculation of polarized
Caco-2 cells on either apical (open bars) or basolateral (shaded bars)
cell surfaces at an MOI of approximately 6 RFU/cell. The results shown
represent the means of the cell-associated virus content of three
replicate infected cultures (± standard deviation).
|
|
Uncoating of HAV is thought to occur very slowly following cellular
entry (
22,
39). Thus, the quantity of infectious virus
associated with cells immediately after the 2-h adsorption period
may
be taken as a reasonable measure of virus attachment and cellular
receptor activity, even when virus adsorption is carried out at
physiologic temperatures. The proportion of the HAV inoculum remaining
associated with the monolayer following adsorption and a series
of two
washes with medium was approximately 1.1% when the inoculum
was placed
on the apical cell surface, compared with only 0.0008%
following
adsorption to the basolateral surface of Caco-2 cells,
a 1,375-fold
difference (Table
1).
To determine the extent to which the rate of virus diffusion through
the Transwell-COL membrane may have limited the uptake
of virus from
the basolateral medium, we measured the ability
of virus to diffuse
through the membrane in the absence of a cell
monolayer. A virus
inoculum was placed on the basolateral side
of the membrane, and the
titer of virus in fluids on both sides
of the membrane following a 2-h
mock adsorption period was measured.
Virus titers in the apical fluid
ranged from 10 to 13% of those
in the basolateral fluid at the end of
the incubation period and
were 5.0 to 6.6% of the original inoculum.
Furthermore, although
the quantity of virus in the basolateral and
apical inocula were
kept identical in order to maintain a constant MOI
(Fig.
3), the
larger volume of the basolateral chamber of the
Transwell-COL
inserts resulted in a lower concentration of virus in the
basolateral
medium (22% that of the inoculum in the apical chamber)
(see Materials
and Methods). Taken together, the limited diffusion
across the
membrane and the difference in volume in the two chambers
suggest
that the concentration of virus at the basolateral cell surface
may have been only 2.2 to 2.9% of that present at the apical surface
in the experiment shown in Fig.
3. While this may explain some
of the
1,375-fold difference that was evident in the uptake of
virus from the
apical versus basolateral inoculum (Table
1),
the much smaller fraction
of cell-associated virus following basolateral
inoculation cannot be
explained entirely by differences in virus
concentration at the cell
surfaces. Thus, we conclude that the
cellular uptake of HAV occurs
asymmetrically in these polarized
cells. Even taking into consideration
differences in the virus
concentration at the basolateral membrane,
virus uptake via the
apical membranes of Caco-2 cells is at least 30- to 40-fold (that
is, 2.2 to 2.9% of 1,375-fold) more efficient than
uptake via
the basolateral membranes. These results clearly distinguish
HAV
from poliovirus, which was capable of bidirectional entry into
Caco-2 cells in similar experiments (
36).
Infection of Caco-2 cells with HM175/18f virus is noncytopathic and
does not disturb the integrity of polarized monolayers.
HM175/18f
virus has a rapid replication/cytopathic
(rr/cpe+) phenotype in BS-C-1 cells that leads
to cellular degeneration and visible plaques when the virus is
propagated in these cells under an agarose overlay (22).
These phenotypic attributes distinguish this virus from its wild-type
parent and are due to complex interactions between multiple mutations
in the 5' nontranslated and P2/P3 (nonstructural) regions of the genome
which contribute to both enhanced viral translation and RNA replication
(41). It was of interest, therefore, to see whether
infection of polarized Caco-2 cells would affect the integrity of the
monolayer. To address this, we analyzed duplicate monolayer cultures of
Caco-2 cells for [3H]inulin permeability following apical
infection with this virus under the conditions used for the experiment
shown in Fig. 3. As shown in Fig. 4,
HM175/18f virus infection did not result in an increase in permeability
to [3H]inulin. Immediately following the adsorption
period, the mean rate of [3H]-inulin diffusion from
apical to basolateral compartments was 0.86%/h (compared with 61%/h
in the absence of the cell monolayer). A rate of inulin diffusion of
less than 1%/h across the monolayer is indicative of the presence of
intact junctional complexes (36). Inulin permeability
continued to demonstrate a slow downward trend over the ensuing 7 days
of the infection (mean diffusion was 0.49%/h on day 7) (Fig. 4),
indicating a strengthening of junctional complexes during the course of
the experiment. These results were consistent with transepithelial
resistance measurements which were not reduced following infection of
Caco-2 monolayers over a similar period (data not shown).

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 4.
Permeability of Caco-2 cells to [3H]inulin
following infection with HAV. Duplicate monolayer cultures of polarized
Caco-2 cells were infected by apical inoculation of virus under the
conditions employed for the experiment shown in Fig. 2. At the
intervals noted following infection, the apical-to-basolateral
diffusion of [3H]inulin was measured over a 90-min
period. The results shown represent the mean hourly rate (± range) of
[3H]inulin diffusion. A rate of inulin diffusion of less
than 1%/h across the monolayer indicates the presence of intact
junctional complexes. Diffusion across the porous support in the
absence of cells approximated 61%/h.
|
|
The integrity of infected monolayers was also confirmed by transmission
electron microscopy. Examination of thin sections
of Caco-2 cells which
were fixed 72 h after apical inoculation
with the virus revealed
an intact cellular architecture (data
not shown). Tight junctions were
well defined, consistent with
retention of monolayer integrity.
Mitochondria and membranes of
the endoplasmic reticulum appeared
normal, and virus particles
were not identifiable. This is not
surprising, given the relatively
low yield of HAV in these cells. These
studies revealed no evidence
of a cytolytic
infection.
Release of progeny virions from infected Caco-2 cells occurs in a
vectorial fashion through the apical membrane.
Newly replicated
HAV particles were released from apically infected polarized Caco-2
cells almost exclusively through the apical surface (Fig.
5). The amount of virus released into the apical supernatant fluids increased exponentially between 24 and 48 h postinfection and continued to rise slowly, reaching a
plateau at approximately 5 × 106 RFU/culture/day by
days 6 and 7 (Fig. 5A). In contrast, the maximal amount of virus
released into basolateral culture fluids was 1.7 × 104 RFU/culture/day. The proportion of all released virus
which was directed into the apical supernatant fluids was remarkably
constant throughout the 7-day period of observation, ranging from
98.9% to 99.7% (Fig. 5B), with only 0.26 to 1.1% released into the
basolateral supernatant fluids. The release of virus from basolaterally
infected cells was similarly restricted to the apical surface (data not shown).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 5.
Vectorial release of HAV from apically infected
polarized Caco-2 cell monolayers. Cells were inoculated as in Fig. 2
and washed prior to refeeding following the 2-h adsorption period.
Apical and basolateral supernatant fluids were collected at 24-h
intervals for virus titration and replaced with fresh media. (A) Virus
content of apical (open bars) and basolateral (shaded bars) supernatant
fluids. The values shown represent the mean virus titer of fluids from
three replicate infected cultures (± standard deviation). (B)
Proportion of all released virus (apical plus basolateral supernatant
fluid virus) released into apical (open bars) or basolateral (shaded
bars) fluids. The results shown represent the means of three replicate
cultures at each time point, as in panel A.
|
|
The absence of any decline in the quantity of virus released into the
apical supernatant fluids over the 7-day observation
period is
consistent with the establishment of a persistent infection.
This is
typical of HAV infection in cultured cells (
17,
22).
Between
24 and 72 h postinfection, the mean number of infectious
virus
particles released into the apical supernatant fluids was
2.0 × 10
6 RFU per culture insert (combined virus contents of the
48- and
72-h supernatant fluids). Because each insert contained
3.5 ×
10
5 cells at the start of the infection, this
represents the release
of an average of only 6 infectious virus
particles per Caco-2
cell during this 48-h period. Since the total
cell-associated
virus increased from a mean of 2.9 × 10
4 to 2.9 × 10
6 RFU/culture, or by an
average of approximately 8 RFU per cell,
between 24 and 72 h (Fig.
3), it can be deduced that about 40%
of newly replicated infectious
virus particles were released into
the apical supernatant fluids. These
are minimal estimates, because
they do not take into account the steady
loss of viability of
virus particles secreted into the medium. Even so,
since the experiment
shown in Fig.
2 documented that 50 to 80% of
Caco-2 cells contain
detectable HAV antigen by 4 to 8 days after
infection, these data
indicate that Caco-2 cells support only a low
level of productive
infection.
Absence of transcytosis of HAV by polarized Caco-2 cells.
The
small proportion of newly replicated virus found in the basolateral
supernatant fluids of apically infected Caco-2 cultures (Fig. 5B) could
reflect transcytosis of virus present within the apical medium rather
than basolateral release of progeny intracellular virions. To address
this question, we determined the efficiency of apical-to-basolateral
and basolateral-to-apical transcytosis of virus. Polarized cultures of
Caco-2 cells were inoculated with HAV on either apical or basolateral
surfaces, as described above, and the virus titers in the contralateral
supernatant fluid were determined after a 2-h incubation period (Table
2). Less than 0.002% of an apical
inoculum was transported (or diffused) into the basolateral fluid,
while less than 0.0004% of a basolateral inoculum was transported into
the contralateral apical supernatant fluid. The proportion of an apical
inoculum transported into basolateral fluids following a 24-h
incubation period (without removal of the apical inoculum) was not
significantly increased (Table 2). These data do not support the
presence of significant transcytosis of HAV by polarized Caco-2 cell
cultures and suggest that the small proportion of virus present in
basolateral fluids of apically infected cells (0.3 to 1.1% of total
released virus [Fig. 5B]) reflects low-level release of
intracellularly replicated virus or possibly the presence of a small
number of incompletely polarized cells in the culture.
Brefeldin A inhibits replication and vectorial release of HAV from
Caco-2 cells.
The nearly exclusive apical release of HAV from
infected cells in the absence of significant cellular cytopathology
suggests a possible role for normal protein sorting and vesicular
transport mechanisms in the movement of progeny virions out of infected Caco-2 cells. To evaluate this possibility, we determined the effects
of brefeldin A on the replication and release of HAV from polarized
Caco-2 cells. Brefeldin A is a fungal metabolite which disrupts the
Golgi complex in many cell types, with resulting inhibition of normal
cellular sorting and transport functions (15, 27). It also
has been shown to inhibit the replication of some picornaviruses by
interfering with the assembly and/or function of cytoplasmic membranous
complexes required for viral RNA replication (12, 26, 37).
Its effects on replication of members of this genus of the
Picornaviridae have not been studied previously.
Polarized cultures of Caco-2 cells were inoculated with HAV on the
apical surface and fed with medium containing brefeldin
A beginning
immediately after the 2-h viral adsorption period.
Even the lowest
concentration of brefeldin A tested (0.1 µg/ml)
resulted in a
profound reduction in the subsequent total virus
yield (cell-associated
HAV plus virus present in apical and basolateral
supernatant fluids) at
72 h postinfection (1.4% of control virus
yield) (Fig.
6A). Somewhat greater inhibition of HAV
replication
was noted at higher concentrations of the drug (0.41 to
0.59%
control yields at concentrations of

0.5 µg/ml). When
brefeldin
A (10 µg/ml) was added at 18 h postinfection,
replication was
still substantially inhibited (4.7% of control yield),
whereas
the addition of brefeldin A to medium at 36 h
postinfection had
a significantly reduced effect (39% of control
yield) (Fig.
6B).
These data indicate that brefeldin A blocks the
logarithmic increases
in virus titer that normally occur between 24 and
48 h postinfection
in Caco-2 cells (see Fig.
1 and
5A), consistent
with an inhibition
of viral RNA synthesis, as noted for poliovirus
(
26). Brefeldin
A inhibition of HAV replication in polarized
Caco-2 cells coincided
with morphological changes involving rounding of
the cells, as
well as a dramatic decrease in the transepithelial
resistance.
Resistance decreased within 18 h of treatment and
ranged from
43 to 56

-cm
2 for infected cell sheets after
72 h of brefeldin A treatment
at all concentrations of the drug.
Resistance averaged 182

-cm
2 for control infected cells.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 6.
Brefeldin A (BFA) inhibits HAV replication in Caco-2
cells. (A) Replicate cultures of apically inoculated Caco-2 cells were
fed with medium containing various concentrations of brefeldin A
beginning immediately after the 2-h period of viral adsorption.
Brefeldin A was replenished every 6 h, and the medium was replaced
daily. The results shown represent the mean total virus yield
(cell-associated plus apical and basolateral fluid virus [± range])
at 72 h postinfection as a percentage of the yield from control
cells infected in the absence of brefeldin A. (B) Effect of late
addition of brefeldin A to apically inoculated Caco-2 cells. Cells were
infected as in panel A with brefeldin A (10 µg/ml) added at various
times postinfection. As in panel A, the results shown represent the
mean total virus yield (± range) at 72 h postinfection as a
percentage of virus yield from cells infected in the absence of
brefeldin A.
|
|
In addition to inhibiting the replication of virus, concentrations of
brefeldin A of

0.5 µg/ml also resulted in a reduction
in the
proportion of newly replicated HAV released into apical
supernatant
fluids (Fig.
7A). While about 36% of the
virus yield
was released into the apical fluids in the absence of
brefeldin
A in the experiment shown in Fig.
7, this fell to about 27%
at
0.5 µg of brefeldin A per ml and to only 12% at higher
concentrations
of the drug (5 µg/ml). The proportion of virus
released into apical
(or basolateral) fluids at the maximal
concentration of brefeldin
A (10 µg/ml) could not be measured, due to
a combination of the
low virus yield and the residual antiviral
activities of brefeldin
A in the supernatant fluid. The decrease in the
proportion of
the virus yield that was found in the apical supernatant
fluids
suggests that release of virus may involve vesicular transport
pathways that are disrupted by brefeldin A (see Discussion). The
effect
of brefeldin A (10 µg/ml) on the proportion of virus undergoing
apical transport was reduced when the drug was added at 18 h or
later postinfection (19 to 28% of virus transported into apical
fluids, compared with 48% apical release from control cells) (data
not
shown). This correlated with somewhat higher transepithelial
resistance
readings in these cells (60 to 83

-cm
2), but suggests
that brefeldin A may have a lesser effect on the
transport of virus
which has already been replicated prior to
perturbation of vesicular
transport by the drug.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 7.
Brefeldin A (BFA) inhibits apical release of progeny
HAV. Cells were treated with various concentrations of brefeldin A
beginning immediately after removal of an apical HAV inoculum, as in
Fig. 6A. The proportion of the total virus yield (cell-associated plus
apical and basolateral fluid virus) that was present in the apical (A)
or basolateral (B) supernatant fluids 72 h postinfection was
calculated for each culture. The results shown represent the mean (± range) results for replicate cultures treated with the drug and the
mean (± standard deviation) of five cultures maintained in the absence
of brefeldin A. Samples of apical and basolateral fluids from cells
treated with 10 µg of brefeldin A per ml could not be assayed for HAV
due to residual antiviral activity.
|
|
In contrast to the inhibition of apical release of HAV observed with
higher concentrations of brefeldin A, the release of
virus into
basolateral fluids was modestly increased. The fraction
of the virus
yield present in the basolateral supernatant at 72
h was only
0.23% in the absence of the drug, but this rose to
as high as 11% at
5 µg/ml (Fig.
7B). At this concentration of
the drug, approximately
equal proportions of the virus yields
were present in the apical and
basolateral fluids. While it is
possible that this reflects disordered
sorting of virus, it may
also be due to the impairment of monolayer
integrity and increased
paracellular leaks suggested by the reductions
in transepithelial
resistance (see above). Nonetheless, in Caco-2 cells
treated with
brefeldin A concentrations up to 5 µg/ml for 72 h
beginning immediately
after HAV inoculation, 77% of the total virus
yield remained cell
associated, compared with 63% in the absence of
drug. This indicates
that the cytotoxic effects of brefeldin A were
limited in terms
of cellular lysis or physical disruption of the
monolayer.
Effect of monensin on apical release of virus.
Monensin is a
carboxylic ionophore which arrests vesicular transport at a site
located distal to the proximal portion of the Golgi complex (5,
35). To determine whether it is capable of causing a dose-related
reduction in apical transport of HAV, we infected polarized Caco-2
cells by the apical route. After 72 h, the cells were washed and
refed with medium containing monensin (10
7 to
10
9 M). The quantity of virus released into the apical
supernatant fluids was then assessed over the ensuing 6-h period. Even
when added to cultures this late in the infection cycle, the highest concentration of monensin tested (10
7 M) resulted in an
~50% decrease in virus released into the apical fluids (Fig.
8). These results are consistent with the
involvement of vesicular secretory pathways in the apical release of
virus from polarized Caco-2 cells. Under similar experimental
conditions, there was no inhibition of the apical release of virus by
brefeldin A (0.5 µg/ml).

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 8.
Monensin inhibits apical release of HAV from polarized
Caco-2 cells. Cells were treated with the indicated concentration of
monensin beginning 72 h after apical infection with HAV. The
quantity of virus released into the apical supernatant fluids was then
assessed after a 6-h incubation period and is shown as the percentage
of virus present in the cell lysate (± range). The titer of virus
present in the lysates of cells treated with the highest concentration
of monensin (10 7 M) was 93% (range, 87 to 100%) of that
present in untreated cells, indicating there was no antiviral effect
over this short incubation period.
|
|
 |
DISCUSSION |
Although the intracellular sorting of viral proteins involved in
the morphogenesis of enveloped viruses by polarized cells has received
considerable attention, relatively little information is available
concerning the interactions of nonenveloped viruses with polarized
cells (3). Simian virus 40 (SV40) and poliovirus have been
studied most extensively and have contrasting properties in terms of
virus entry and release (4, 5, 36, 37). HAV differs from
both of these viruses in that its replication is not associated with a
demonstrable cytopathic effect in Caco-2 cells, potentially allowing a
clearer view of the specific mechanisms controlling release of
nonenveloped viruses from infected cells.
We found that HAV infection of Caco-2 cells occurred much more
efficiently following inoculation of the apical compared to the
basolateral surface of these cells (Fig. 3). In addition, approximately
1,000-fold more virus remained associated with these cells following a
2-h period of apical, versus basolateral, exposure to virus at an
equivalent multiplicity (Table 1). Direct measurements of virus
diffusion indicated that this difference could not be explained
entirely by slow virus diffusion across the support membrane or the
4.5-fold-lower concentration of virus in the basolateral medium that
resulted from efforts to keep the MOI constant in these experiments.
Taking these variables into account, the uptake of virus was at least
30- to 40-fold more efficient via the apical surface.
The results obtained in these experiments thus suggest that the
cellular receptor for HAV may be present in greater abundance on the
apical compared to the basolateral surface of Caco-2 cells. However,
this does not mean that the receptor is necessarily present at greater
density on the apical surface, because the surface area of the apical
membrane with its numerous microvilli is much greater than that of the
basolateral surface. It is not possible to test this hypothesis
directly, since the functional receptor expressed by Caco-2 cells may
differ from the HAV receptor identified recently on human liver and
kidney cells (8). Nonetheless, the asymmetric attachment and
entry we observed with HAV resemble previous observations with SV40
virus (4). The cellular receptor for SV40 virus was found to
be expressed only on the apical surfaces of polarized Vero C1008 or
Madin-Darby canine kidney cell cultures (4). Significantly,
our results distinguish HAV from both poliovirus and rotavirus, which
are capable of efficiently initiating infection from either surface of
polarized Caco-2 cell cultures (34, 36), and astrovirus,
which may infect exclusively from the basolateral surface
(40). A striking feature of our studies is the very low
proportion of virus that was bound to or taken up by either side of the
monolayer at the end of the adsorption period (Table 1).
Release of progeny HAV virions occurred almost exclusively via the
apical cellular membrane (Fig. 5). The small proportion of released
virus (generally less than 1%) that was present in basolateral culture
fluids may reflect either limited basolateral release of virus from
polarized cells or the existence of a small proportion of incompletely
polarized cells in the cultures (4). This vectorial release
of newly replicated HAV is strikingly similar to the apically directed
vectorial release of both poliovirus and SV40 from polarized cells
(33, 37). With both poliovirus and SV40, apical release of
progeny virions appeared to occur prior to the lysis of cells that is
induced by these cytopathic viruses (5, 37). However,
infection with either of these viruses results in the eventual
destruction of the cell monolayer. Thus, it is possible that the apical
release of these viruses reflects early disruption of the apical plasma
membrane due to virus-induced cytopathology. Since HAV infection of
Caco-2 cells has no impact on monolayer integrity as assessed by
transepithelial resistance, [3H]inulin permeability (Fig.
4), or transmission electron microscopy, the apical release of this
noncytopathic virus provides strong evidence that specific mechanisms
exist for vectorial release of nonenveloped viruses that are not
dependent upon cellular lysis.
What might be the nature of such a specific virus release mechanism?
The involvement of the normal protein sorting and vesicular transport
apparatus of the cell is suggested by the inhibition of vectorial HAV
release that we observed in cells treated with brefeldin A or monensin
(Fig. 7 and 8). Brefeldin A, a fungal metabolite, is known to block the
anterograde movement of proteins from the rough endoplasmic reticulum
to the proximal Golgi complex (15, 27). This and possibly
other actions of brefeldin A result in disruption of the Golgi complex
and profound but reversible dysregulation of intracellular vesicular
transport in many cell types (15, 23, 27). Brefeldin A also
has been shown to have potent antiviral activity against some but not
all picornaviruses due to inhibition of viral RNA replication (12,
26). We confirmed that this antiviral activity extends to HAV
(Fig. 6), but we also demonstrated that brefeldin A induces substantial
dose-related reductions in the transport of newly replicated virions
across the apical plasma membrane of Caco-2 cells (Fig. 7A). We also found that monensin, a carboxylic ionophore which arrests vesicular transport at a site located distal to the proximal portion of the Golgi
complex (5, 35), caused a moderate dose-related reduction in
apical transport of HAV, even when added to cultures late in the
infection cycle (Fig. 8). It is interesting that the apical release of
poliovirus, which like HAV is a member of the Picornaviridae, was not selectively inhibited by either
brefeldin A or monensin (37). This suggests a mechanism of
vectorial release that is distinct from that of HAV and not dependent
on conventional vesicular transport. Perhaps this is not too
surprising, because expression of the poliovirus 2B and 3A proteins
during virus infection results in profound disruption of vesicular
transport (7), a phenomenon that is not likely to accompany
the noncytopathic replication of HAV. Our results also contrast with
the lack of inhibition of the apical release of rotavirus by monensin,
which appears to exit Caco-2 cells by a noncanonical vesicular
transport mechanism that bypasses the Golgi apparatus (13).
It is interesting to consider how these observations of apical entry
and release of HAV from Caco-2 cells relate to the pathogenesis of
hepatitis A in humans. Caco-2 cells most closely resemble epithelial cells of the small intestinal villi and crypts (9, 29) and are thus closely related to the cells within which HAV replication has
been identified in infected owl monkeys (2). The ability of
Caco-2 cells to be infected following apical exposure to virus is thus
consistent with the observation that intestinal epithelial cells are
infected by virus present within the lumen of the gastrointestinal tract (2, 14). The vectorial apical release of newly
replicated virus from these cells would result in an increase in the
amount of virus present within the lumen of the gastrointestinal tract and an amplification of the inoculum. Thus, it may be necessary to
reconsider the generally held view that most if not all of the virus
which is shed in feces during hepatitis A is derived from the liver
rather than replicated within the intestinal epithelium (17). However, the restricted basolateral release of HAV
also suggests that epithelial cell infection is unlikely to result in
penetration of the virus beyond the gastrointestinal epithelium. Thus,
HAV invasion of deeper tissues, a requirement for its eventual passage
to the liver, may be dependent upon alternate mechanisms. One
possibility is transcytosis by specialized M cells overlying Peyer's
patches in the distal ileum, as appears to be the case for both
poliovirus and reovirus (1, 33). Proximal epithelial cell
infection could, however, play an important role in amplifying the
inoculum ultimately reaching these M cells.
The primary target cell for HAV, the hepatocyte, is also an epithelial
cell with defined polarity. Its basolateral membrane faces the venous
sinusoids, and its apical surface forms the interface with the biliary
canaliculi. The involvement of vesicular transport in the egress of HAV
from hepatocytes is consistent with early electron microscopic studies
of liver sections from patients and nonhuman primates infected with
HAV, in which the virus in hepatocytes was found to be present within
cytoplasmic vesicles possibly derived from the rough endoplasmic
reticulum (10, 32). However, vesicular transport in
hepatocytes differs from that of other polarized cells (including
Caco-2 cells) in that hepatocytes are deficient in direct vesicular
transport of proteins to the apical plasma membrane (6, 11).
Instead, proteins generally reach the apical plasma membrane of
hepatocytes via an indirect route, with sorting first to the
basolateral surface followed by transport to the apical membrane. For
example, dipeptidyl peptidase IV, a type II membrane glycoprotein
expressed on the apical surface of various epithelial cells, is known
to undergo direct intracellular transport to the apical membrane in
some cell types, but indirect transport with transcytosis from the
basolateral to the apical membrane in hepatocytes (24).
Thus, it is likely that apical secretion of HAV from hepatocytes occurs
by a process that is different from apical secretion in infected Caco-2
cells. Nonetheless, some canalicular (apical)
glycophosphatidylinositol-linked proteins may reach their final
destination by a direct transport mechanism in hepatocytes
(38). In addition, cellular transport proteins have been
identified which function in the direct transport of biliary lipids and
bile salts to the canalicular surface (6). It is possible
that HAV in some way parasitizes these cellular pathways to achieve its
release from hepatocytes into the bile.
 |
ACKNOWLEDGMENTS |
We thank David Rowlands, Kara Stanig, Masao Honda, and Stephen
Knight for helpful discussions. We also thank Vicky Madden for
outstanding assistance with electron microscopy and Paula Murphy, Geoff
Abell, and Terry Chapa for excellent technical assistance.
This work was supported in part by a grant (RO1-AI32599) from the
National Institute of Allergy and Infectious Diseases.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, The University of Texas Medical Branch at Galveston, 301 University Blvd., Galveston, TX 77555-1019. Phone: (409)
772-2324. Fax: (409) 772-3757. E-mail: smlemon{at}utmb.edu.
 |
REFERENCES |
| 1.
|
Amerongen, H. M.,
G. A. Wilson,
B. N. Fields, and M. R. Neutra.
1994.
Proteolytic processing of reovirus is required for adherence to intestinal M cells.
J. Virol.
68:8428-8432[Abstract/Free Full Text].
|
| 2.
|
Asher, L. V. S.,
L. N. Binn,
T. L. Mensing,
R. H. Marchwicki,
R. A. Vassell, and G. D. Young.
1995.
Pathogenesis of hepatitis A in orally inoculated owl monkeys (Aotus trivergatus).
J. Med. Virol.
47:260-268[Medline].
|
| 3.
|
Blau, D. M., and R. W. Compans.
1996.
Polarization of viral entry and release in epithelial cells.
Semin. Virol.
7:245-253.
|
| 4.
|
Clayson, E. T., and R. W. Compans.
1988.
Entry of simian virus 40 is restricted to apical surfaces of polarized epithelial cells.
Mol. Cell. Biol.
8:3391-3396[Abstract/Free Full Text].
|
| 5.
|
Clayson, E. T.,
L. V. Jones-Brando, and R. W. Compans.
1989.
Release of simian virus 40 virions from epithelial cells is polarized and occurs without cell lysis.
J. Virol.
63:2278-2288[Abstract/Free Full Text].
|
| 6.
|
Crawford, J. M.
1996.
Role of vesicle-mediated transport pathways in hepatocellular bile secretion.
Semin. Liver Dis.
16:169-189[Medline].
|
| 7.
|
Doedens, J. R., and K. Kirkegaard.
1995.
Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A.
EMBO J.
14:894-907[Medline].
|
| 8.
|
Feigelstock, D.,
P. Thompson,
P. Mattoo,
Y. Zhang, and G. G. Kaplan.
1998.
The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor.
J. Virol.
72:6621-6628[Abstract/Free Full Text].
|
| 9.
|
Hidalgo, I. J.,
R. J. Raub, and R. T. Borchardt.
1989.
Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability.
Gastroenterology
96:736-749[Medline].
|
| 10.
|
Huang, S.-N.,
D. Lorenz, and R. J. Gerety.
1979.
Electron and immunoelectron microscopic study on liver tissues of marmosets infected with hepatitis A virus.
Lab. Investig.
41:63-71[Medline].
|
| 11.
|
Hubbard, A. L.,
V. A. Barr, and L. J. Scott.
1994.
Hepatocyte surface polarity, p. 189-213.
In
I. M. Arias, J. L. Boyer, N. Fausto, W. B. Jakoby, D. A. Schachter, and D. A. Shafritz (ed.), The liver: biology and pathobiology. Raven Press, Ltd., New York, N.Y.
|
| 12.
|
Irurzun, A.,
L. Perez, and L. Carrasco.
1992.
Involvement of membrane traffic in the replication of poliovirus genomes: effects of brefeldin A.
Virology
191:166-175[CrossRef][Medline].
|
| 13.
|
Jourdan, N.,
M. Maurice,
D. Delautier,
A. M. Quero,
A. L. Servin, and G. Trugnan.
1997.
Rotavirus is released from the apical surface of cultured human intestinal cells through nonconventional vesicular transport that bypasses the Golgi apparatus.
J. Virol.
71:8268-8278[Abstract].
|
| 14.
|
Karayiannis, P.,
T. Jowett,
M. Enticott,
D. Moore,
M. Pignatelli,
F. Brenes,
P. J. Scheuer, and H. C. Thomas.
1986.
Hepatitis A virus replication in tamarins and host immune response in relation to pathogenesis of liver cell damage.
J. Med. Virol.
18:261-276[Medline].
|
| 15.
|
Klausner, R. D.,
J. G. Donaldson, and J. Lippincott-Schwartz.
1992.
Brefeldin A: insights into control of membrane traffic and organelle structure.
J. Cell Biol.
116:1071-1080[Free Full Text].
|
| 16.
|
Krawczynski, K. K.,
D. W. Bradley,
B. L. Murphy,
J. W. Ebert,
T. E. Anderson,
I. L. Doto,
A. Nowoslawski,
W. Duermeyer, and J. E. Maynard.
1981.
Pathogenetic aspects of hepatitis A virus infection in enterally inoculated marmosets.
Am. J. Clin. Pathol.
76:698-706[Medline].
|
| 17.
|
Lemon, S. M.
1985.
Type A viral hepatitis: new developments in an old disease.
N. Engl. J. Med.
313:1059-1067[Medline].
|
| 18.
|
Lemon, S. M., and B. H. Robertson.
1993.
Current perspectives in the virology and molecular biology of hepatitis A virus.
Semin. Virol.
4:285-295.
|
| 19.
|
Lemon, S. M., and C. N. Shapiro.
1994.
The value of immunization against hepatitis A.
Infect. Agents Dis.
3:38-49[Medline].
|
| 20.
|
Lemon, S. M.,
J. W. LeDuc,
L. N. Binn,
A. Escajadillo, and K. G. Ishak.
1982.
Transmission of hepatitis A virus among recently captured Panamanian owl monkeys.
J. Med. Virol.
10:25-36[Medline].
|
| 21.
|
Lemon, S. M.,
L. N. Binn, and R. H. Marchwicki.
1983.
Radioimmunofocus assay for quantitation of hepatitis A virus in cell cultures.
J. Clin. Microbiol.
17:834-839[Abstract/Free Full Text].
|
| 22.
|
Lemon, S. M.,
P. C. Murphy,
P. A. Shields,
L.-H. Ping,
S. M. Feinstone,
T. Cromeans, and R. W. Jansen.
1991.
Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection: evidence for genetic recombination.
J. Virol.
65:2056-2065[Abstract/Free Full Text].
|
| 23.
|
Liu, E. S.,
J. Ou, and A. S. Lee.
1992.
Brefeldin A as a regulator of grp78 gene expression in mammalian cells.
J. Biol. Chem.
267:7128-7133[Abstract/Free Full Text].
|
| 24.
|
Low, S.,
S. Wong,
B. L. Tang,
V. N. Subramaniam, and W. Hong.
1991.
Apical cell surface expression of rat dipeptidyl peptidase IV in transfected Madin-Darby canine kidney cells.
J. Biol. Chem.
266:13391-13396[Abstract/Free Full Text].
|
| 25.
|
Mathiesen, L. R.,
A. M. Møller,
R. H. Purcell,
W. T. London, and S. M. Feinstone.
1980.
Hepatitis A virus in the liver and intestine of marmosets after oral inoculation.
Infect. Immun.
28:45-48[Abstract/Free Full Text].
|
| 26.
|
Maynell, L. A.,
K. Kirkegaard, and M. W. Klymkowsky.
1992.
Inhibition of poliovirus RNA synthesis by brefeldin A.
J. Virol.
66:1985-1994[Abstract/Free Full Text].
|
| 27.
|
Pelham, H. R. B.
1991.
Multiple targets for brefeldin A.
Cell
67:449-451[CrossRef][Medline].
|
| 28.
|
Pinto, M.,
S. Robine-Leon,
M. D. Appay,
M. Kedinger,
N. Triadou,
E. Dussauix,
B. Lacroix,
P. Simon-Assmann,
K. Haffen,
J. Fogh, and A. Zweibaum.
1983.
Enterocyte-like differentiation and polarization of the human colonic carcinoma cell line CaCo-2 in culture.
Biol. Cell
47:323-330.
|
| 29.
|
Quaroni, A.
1986.
Crypt cell antigen expression in human colon tumor cell lines: analysis with a panel of monoclonal antibodies to CaCo-2 luminal membrane components.
J. Natl. Cancer Inst.
76:571-585.
|
| 30.
|
Rothman, J. E., and F. T. Wieland.
1996.
Protein sorting by transport vesicles.
Science
272:227-234[Abstract].
|
| 31.
|
Schulman, A. N.,
J. L. Dienstag,
D. R. Jackson,
J. H. Hoofnagle,
R. J. Gerety,
R. H. Purcell, and L. F. Barker.
1976.
Hepatitis A antigen particles in liver, bile, and stool of chimpanzees.
J. Infect. Dis.
134:80-84[Medline].
|
| 32.
|
Shimizu, Y. K.,
T. Shikata,
P. R. Beninger,
M. Sata,
H. Setoyama,
H. Abe, and K. Tanikawa.
1982.
Detection of hepatitis A antigen in human liver.
Infect. Immun.
36:320-324[Abstract/Free Full Text].
|
| 33.
|
Sicinski, P.,
J. Rowinski,
J. B. Warchol,
Z. Jarzcabek,
W. Gut,
B. Szczygiel,
K. Bielecki, and G. Koch.
1990.
Poliovirus type 1 enters the human host through intestinal M cells.
Gastroenterology
98:56-58[Medline].
|
| 34.
|
Svensson, L.,
B. B. Finlay,
D. Bass,
C.-H. von Bonsdorff, and H. B. Greenberg.
1991.
Symmetric infection of rotavirus on polarized human intestinal epithelial (Caco-2) cells.
J. Virol.
65:4190-4197[Abstract/Free Full Text].
|
| 35.
|
Tartakoff, A. M.
1983.
Perturbation of vesicular traffic with the carboxylic ionophore monensin.
Cell
32:1026-1028[CrossRef][Medline].
|
| 36.
|
Tucker, S. P.,
C. L. Thornton,
E. Wimmer, and R. W. Compans.
1993.
Bidirectional entry of poliovirus into polarized epithelial cells.
J. Virol.
67:29-38[Abstract/Free Full Text].
|
| 37.
|
Tucker, S. P.,
C. L. Thornton,
E. Wimmer, and R. W. Compans.
1993.
Vectorial release of poliovirus from polarized human intestinal epithelial cells.
J. Virol.
67:4274-4282[Abstract/Free Full Text].
|
| 38.
|
Wehner, F.,
R. KH. Kinne, and E. Petzinger.
1996.
Second International Ringberg Conference: Cell Biology and Molecular Basis of Liver Transport.
Hepatology
24:259-267[Medline].
|
| 39.
|
Wheeler, C. M.,
H. A. Fields,
C. A. Schable,
W. J. Meinke, and J. E. Maynard.
1986.
Adsorption, purification, and growth characteristics of hepatitis A virus strain HAS-15 propagated in fetal rhesus monkey kidney cells.
J. Clin. Microbiol.
23:434-440[Abstract/Free Full Text].
|
| 40.
|
Willcocks, M. M.,
M. J. Carter, and C. R. Madeley.
1992.
Astrovirus.
Rev. Med. Virol.
2:97-106.
|
| 41.
|
Zhang, H. C.,
S. F. Chao,
L. H. Ping,
K. Grace,
B. Clarke, and S. M. Lemon.
1995.
An infectious cDNA clone of a cytopathic hepatitis A virus: genomic regions associated with rapid replication and cytopathic effect.
Virology
212:686-697[CrossRef][Medline].
|
Journal of Virology, July 2000, p. 6476-6484, Vol. 74, No. 14
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wei, T., Hibino, H., Omura, T.
(2008). Rice dwarf virus is engulfed into and released via vesicular compartments in cultured insect vector cells. J. Gen. Virol.
89: 2915-2920
[Abstract]
[Full Text]
-
Snooks, M. J., Bhat, P., Mackenzie, J., Counihan, N. A., Vaughan, N., Anderson, D. A.
(2008). Vectorial Entry and Release of Hepatitis A Virus in Polarized Human Hepatocytes. J. Virol.
82: 8733-8742
[Abstract]
[Full Text]
-
de Jong, A. S., de Mattia, F., Van Dommelen, M. M., Lanke, K., Melchers, W. J. G., Willems, P. H. G. M., van Kuppeveld, F. J. M.
(2008). Functional Analysis of Picornavirus 2B Proteins: Effects on Calcium Homeostasis and Intracellular Protein Trafficking. J. Virol.
82: 3782-3790
[Abstract]
[Full Text]
-
Wessels, E., Duijsings, D., Lanke, K. H. W., van Dooren, S. H. J., Jackson, C. L., Melchers, W. J. G., van Kuppeveld, F. J. M.
(2006). Effects of Picornavirus 3A Proteins on Protein Transport and GBF1-Dependent COP-I Recruitment. J. Virol.
80: 11852-11860
[Abstract]
[Full Text]
-
Dotzauer, A., Brenner, M., Gebhardt, U., Vallbracht, A.
(2005). IgA-coated particles of Hepatitis A virus are translocalized antivectorially from the apical to the basolateral site of polarized epithelial cells via the polymeric immunoglobulin receptor. J. Gen. Virol.
86: 2747-2751
[Abstract]
[Full Text]
-
Fogg, M. H., Teterina, N. L., Ehrenfeld, E.
(2003). Membrane Requirements for Uridylylation of the Poliovirus VPg Protein and Viral RNA Synthesis In Vitro. J. Virol.
77: 11408-11416
[Abstract]
[Full Text]
-
Chu, J. J. H., Ng, M. L.
(2002). Infection of polarized epithelial cells with flavivirus West Nile: polarized entry and egress of virus occur through the apical surface. J. Gen. Virol.
83: 2427-2435
[Abstract]
[Full Text]
-
Pina, S., Buti, M., Jardi, R., Clemente-Casares, P., Jofre, J., Girones, R.
(2001). Genetic analysis of hepatitis A virus strains recovered from the environment and from patients with acute hepatitis. J. Gen. Virol.
82: 2955-2963
[Abstract]
[Full Text]
-
Ciarlet, M., Crawford, S. E., Estes, M. K.
(2001). Differential Infection of Polarized Epithelial Cell Lines by Sialic Acid-Dependent and Sialic Acid-Independent Rotavirus Strains. J. Virol.
75: 11834-11850
[Abstract]
[Full Text]